<DOC>
	<DOC>NCT01355003</DOC>
	<brief_summary>This study will collect safety information on the use of GARDASIL™ in the Philippines.</brief_summary>
	<brief_title>GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)</brief_title>
	<detailed_description />
	<mesh_term>Papillomavirus Infections</mesh_term>
	<criteria>Received GARDASIL™</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>46 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>